Share Search
Visit the Share Search
You are here:
Douglas sure about Shore
12th Oct 2009 17:18
Shares in stockbroker Shore Capital have almost tripled in value since April, but non-executive director Barclay Douglas thinks there's more to come. The accountant has spent £92,000 on 250,000 shares at 36.75p each. He now owns 1.25m shares, or half a per cent of the company. Shore received a sho
Read moreUpdate: Epistem benefits from raised profile
6th Oct 2009 11:37
Drug testing group Epistem moved closer to profit after a research and collaboration deal with the Swiss pharmaceutical giant Novartis helped revenues soar. The firm posted a pre-tax loss of £700,000 in the year to June 30 compared with losses of £1.3m previously, with revenues nearly doubling to £
Read more